(Tokyo, 20 June 2024) Trustar Capital Partners Limited (“Trustar Capital”) announced today that TAUNS Laboratories, Inc. (“TAUNS”, Code:197A), an investment of Trustar Capital Japan Fund III (hereinafter “the Fund”), has been listed on the Tokyo Stock Exchange Standard Market today. TAUNS develops, manufactures, and sells in vitro diagnostics and research reagents. In conjunction with TAUNS’ listing, the Fund has sold a portion of its shares in TAUNS. The market capitalization based on the offering price is approximately JPY50 billion.
Since the early 2000s, TAUNS has been developing rapid diagnostic kits for various infectious diseases, including tuberculosis, influenza, adenovirus, and norovirus. The company’s quality and industry-wide reputation among medical institutions have made it a leading provider of major respiratory infection test kits.
During the COVID-19 pandemic, TAUNS was one of the three companies in Japan, along with two major listed companies, to receive early approval for the manufacture and sale of antigen test kits for COVID-19. TAUNS has a competitive edge in its highly skilled and experienced development team with diverse expertise.
Trustar Capital invested in TAUNS in July 2016 and has since worked closely with the management team to promote the expansion of TAUNS’ business in Japan and overseas market, as well as to improve its governance in preparation for listing. The company has achieved remarkable growth since Trustar Capital’s investment and is now entering a new growth phase. Trustar Capital will continue to support TAUNS’ growth as a shareholder after its listing. TAUNS will continue to expand its market and improve its services to ascertain its leading position in the industry.
The joint lead bookrunners for this transaction are Daiwa Securities Co., Ltd. and Mitsubishi UFJ Morgan Stanley Securities Co., Ltd./Morgan Stanley MUFG Securities Co., Ltd.
– Ends –
About TAUNS Laboratories, Inc.
Established： 1987
Representative：Masaki NONAKA, CEO
Headquarters： 761-1 Kamishima, Izunokuni City, Shizuoka
Website： https://www.tauns.co.jp/en/
About Trustar Capital Partners Limited
Trustar Capital Partners Limited focuses on control buyout opportunities globally and has completed around 100 investments since inception across China, Japan, U.S., Europe, etc. Trustar Capital currently manages USD8.7 billion of committed capital.
Trustar Capital Japan Fund has been providing hands-on support and promoting the growth of mid-sized Japanese companies with strong brand equity and technical capabilities. Since its establishment in 2004, it has made 17 investments.
For more information, please visit http://www.trustarcapital.com/
For media enquiries, please contact:
Cindy TAM
Director, Corporate Relations
CITIC Capital Holdings Limited
Tel: +852 3710 6813
cindytam@citiccapital.com
Irene GAO
Senior Associate, Corporate Relations
CITIC Capital Holdings Limited
Tel: +852 3710 6814
irenegao@citiccapital.com
Takato FUKUDA
Director
Trustar Capital Partners Japan Limited
Tel: +81 3 5211-3830